Significance of selected antioxidant enzymes in cancer cell progress ion

Polish Journal of Pathology

Volumn 65, Issue 3, 2014, Pages 167-175

  Bułdak, Rafał Jakub ^a   Bułdak, LŁukasz ^a   Kukla, Michał ^a   Gabriel, Andrzej ^a   Żwirska Korczala, Krystyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antioxidant enzymes; Cancer progression; Lipid peroxidation; Reactive oxygen species; ROS mediated treatment of cancer

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL; DISEASE COURSE; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DISEASE PROGRESSION; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMANS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84908109215     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/pjp.2014.45779     Document Type: Review

References (73)

1. Goasduff T, Cederbaum AI. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species. Arch Biochem Biophys 1999; 370: 258-270
2. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis 2004; 57: S28-S29
3. Simizu S, Takada M, Umezawa K, et al. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998; 273: 26900-26907
4. Ikeda K, Kajiwara K, Tanabe E, et al. Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. Biochem Pharmacol 1999; 57: 1361-1365
5. Huang HL, Fang LW, Lu SP, et al. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003; 22: 8168-8177
6. Fawcett H, Mader JS, Robichaud M, et al. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells. Int J Oncol 2005; 27: 1717-1726
7. Doroshow JH. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Commun 1986; 135: 330-335
8. Bułdak RJ, Polaniak R, Bułdak L, et al. Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells. Bioelectromagnetics 2012; 33: 641-651
9. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic Biol Med 2001; 30: 1191-212
10. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004; 337: 1-13
11. Perry G, Raina AK, Nunomura A, et al. How important is oxidative damage? Lessons from Alzheimer’s disease. Free Radic Biol Med 2000; 28: 831-834
12. Alexandre J, Nicco C, Chéreau C, et al. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006; 98: 236-244
13. Qian C, Wang Y, Zhong Y, et al. Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells. Free Radic Res 2014; 48: 607-621
14. Fei ZH, Wu K, Chen YL, et al. Capilliposide Isolated from Lysimachia capillipes Hemsl. Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Human Nonsmall Cell Lung Cancer Cell Lines. Evid Based Complement Alternat Med 2014; 2014: 497456
15. Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007; 13: 789-794
16. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579-591
17. Oberley L., Buettner GR. Role of superoxide dismutase in cancer: a review. Cancer Res 1979; 39: 1141-1149
18. Muller A, Cadenas E, Graf P, et al. A novel biologically active seleno-organic compound. Glutathione peroxidase like activity in vitro and antioxidant capacity of ebselen (PZ 51). Biochem Pharmac 1984; 33: 3235-3239
19. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 2004; 151: 335-343
20. Hur GC, Cho SJ, Kim CH, et al. Manganese superoxide dismutase expression correlates with chemosensitivity in human gastric cancer cell lines. Clin Cancer Res 2003; 9: 5768-5775
21. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212
22. Polaniak R, Bułdak RJ, Karoń M, et al. Influence of an extremely low frequency magnetic field (ELF-EMF) on antioxidative vitamin E properties in AT478 murine squamous cell carcinoma culture in vitro. Int J Toxicol 2010; 29: 221-230
23. Palazzotti B, Pani G, Colavitti R, et al. Increased growth capacity of cervical-carcinoma cells over-expressing manganous superoxide dismutase. Int J Cancer 1999; 82: 145-50
24. Janssen AM, Bosman CB, van Duijn W, et al. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res 2000; 6: 3183-3192
25. Malafa M, Margenthaler J, Webb B, et al. MnSOD expression is increased in metastatic gastric cancer. J Surg Res 2000; 88: 130-134
26. Kahlos K, Soini Y, Sormunen R, et al. Expression and prognostic significance of catalase in malignant mesothelioma. Cancer 2001; 91: 1349-1357
27. Li F, Wang H, Huang C, et al. Hydrogen peroxide contributes to the manganese superoxide dismutase promotion of migration and invasion in glioma cells. Free Radic Res 2011; 45: 1154-1161
28. Ganapathy E, Su F, Meriwether D, et al. D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. Int J Cancer 2012; 130: 1071-1081
29. Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas 2003; 26: 23-27
30. Cullen JJ, Oberley L. Role of antioxidant enymes in pancreatic cancer. Free Radic Biol Med 31: 138-140
31. Yoshii Y, Saito A, Hyodo A, et al. Expression of enzymes and oncogene induced after radiotherapy and/or chemotherapy in patients with brain tumors. Hum Cell 2001; 14: 95-103
32. Czeczot H, Scibior D, Skrzycki M, et al. Antioxidant barrier in patients with gastric cancer – preliminary study. Pol Merkur Lekarski 2005; 19: 521-525
33. Zhong W, Oberley L., Oberley TD, et al. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997; 14: 481-490
34. Weydert C, Roling B, Liu J, et al. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther 2003; 2: 361-369
35. Zhong W, Oberley L., Oberley TD, et al. Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth Differ 1996; 7: 1175-1186
36. Fang J, Nakamura H, Iyer AK. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 2007; 15: 475-486
37. Davicino R, Manuele MG, Ferraro G, et al. Modulatory effect of hydrogen peroxide on tumoral lymphocytes proliferation. Immunopharmacol Immunotoxicol 2009; 31: 130-139
38. Liu R, Oberley TD, Oberley LW. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum Gene Ther 1997; 8: 585-595
39. Li JJ, Oberley L., St Clair DK, et al. Phenotypic changes induced in human breast cancer cells by overexpression of manganese- containing superoxide dismutase. Oncogene 1995; 10: 1989-2000
40. Yan T, Oberley L., Zhong W, et al. Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res 1996; 56: 2864-2871
41. Bułdak RJ, Bułdak Ł, Polaniak R, et al. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep 2013; 29: 771-778
42. Buldak RJ, Polaniak R, Buldak L, et al. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma ME45 cells. J Physiol Pharmacol 2013; 64: 377-385
43. Lisanti MP, Martinez-Outschoorn UE, Lin Z, et al. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: The seed and soil also needs “fertilizer” Cell Cycle 2011; 10: 2440-2449
44. Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 2011; 9: 62
45. Glynn SA, Boersma BJ, Howe TM, et al. Mitochondrial Target Sequence Polymorphism in MnSOD Predicts Inferior Survival in Breast CancerPatients Treated with Cyclophosphamide. Clin Cancer Res 2009; 15: 4165-4173
46. Mikhak B, Hunter DJ, Spiegelman D, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels andprostate cancer risk. Carcinogenesis 2008; 29: 2335-2340
47. Connor KM, Hempel N, Nelson KK, et al. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 2007; 67: 10260-10267
48. Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011; 41: 271-290
49. Nelson KK, Ranganathan AC, Mansouri J, et al. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003; 9: 424-432
50. Dusre L, Mimnaugh EG, Myers CE, et al. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res 1989; 49: 511-515
51. Spitz DR, Phillips JW, Adams DT, et al. Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physio 1993; 156: 72-79
52. Versantvoort CH, Broxterman HJ, Bagrij T, et al. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 1995; 72: 82-89
53. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents Canc Treat Rev 2007; 33: 9-23
54. Eriksson SE, Prast-Nielsen S, Flaberg E, et al. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic Biol Med 2009; 47: 1661-1671
55. Corti A, Franzini M, Paolicchi A, et al. Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res 2010; 30: 1169-1181
56. Kuo MT. Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities. Antioxid Redox Signal 2009; 11: 99-133
57. Sobhakumari A, Love-Homan L, Fletcher EV, et al. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism. PLoS One 2012; 7: e48175
58. Samuels BL, Murray JL, Cohen MB, et al. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 1991; 51: 521-527
59. Chuang JI, Chang TY, Liu HS. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Oncogene 2003; 22: 1349-1135
60. Biroccio A, Benassi B, Fiorentino F, et al. Glutathione Depletion Induced by c-Myc Downregulation Triggers Apoptosis on Treatment with Alkylating Agents. Neoplasia 2004; 6: 195-206
61. Brigelius-Flohé R, Flohé L. Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors. Antioxid Redox Signal 2011; 15: 2335-2381
62. Cejas P, Casado E, Belda-Iniesta C, et al. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 2004; 15: 707-719
63. Das UN. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 157-163
64. Bianchi A, Dewailly E, Gautier H, et al. Decrease of human hepatoma cell growth by arachidonic acid is associated with an accumulation of derived products from lipid peroxidation. Biochimie 2004; 86: 633-642
65. Ince S, Kucukkurt I, Cigerci IH, et al. The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxidant activity, and DNA damage in rats. J Trace Elem Med Biol 2010; 24: 161-164
66. Peluso M, Srivatanakul P, Munnia A, et al. Malondialdehyde- deoxyguanosine adducts among workers of a Thai industrial estate and nearby residents. Environ Health Perspect 2010; 118: 55-59
67. Wiswedel I, Gardemann A, Storch A, et al. Degradation of phospholipids by oxidative stress – exceptional significance of cardiolipin. Free Radic Res 2010; 44: 135-145
68. Skapek SX, Colvin OM, Griffith OW, et al. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Res 1988; 48: 2764-2767
69. Yri OE, Vig J, Hegstad E, et al. Mangafodipir as a cytoprotective adjunct to chemotherapy – a case report. Acta Oncol 2009; 48: 633-635
70. Karlsson JO, Adolfsson K, Thelin B, et al. First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study. Transl Oncol 2012; 5: 32-38
71. Zhang J, Gao G, Chen L, et al. Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in humancancer cells. Oncotarget 2014; 5: 841-852
72. Kaibara N, Ikeda T, Hattori T, et al. Experimental studies on enhancing the therapeutic effect of mitomycin-C with hydrogen peroxide. Jpn J Exp Med 1971; 41: 323-329
73. Fang J, Sawa T, Akaike T, et al. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Res 2002; 62: 3138-3143.